Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;19(2):191-199.
doi: 10.1007/s10238-019-00548-9. Epub 2019 Feb 28.

Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients

Marta Łukaszewicz-Zając  1 , Sara Pączek  2 , Paweł Muszyński  3 , Mirosław Kozłowski  4 , Barbara Mroczko  2   3
Affiliations

Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients

Marta Łukaszewicz-Zając et al. Clin Exp Med. 2019 May.

Abstract

C-X-C motif chemokine 8 (CXCL-8), known as interleukin-8, is a pro-inflammatory cytokine which acts as a chemotactic factor, mainly for leukocytes. CXCL-8 is produced by malignant cells, and therefore it can stimulate the growth and progression of various neoplasms, including oesophageal cancer (OC). The aim of the current study was to measure serum concentrations of chemokine CXCL-8 in OC patients and establish whether this protein might be considered a potential candidate for a tumor marker in the diagnosis and progression of OC. The study included 50 OC subjects (32 patients with squamous cell carcinoma of oesophagus-OSCC, 18 patients with adenocarcinoma-OAC) and 26 healthy volunteers. Serum CXCL-8 concentrations were measured using immunoenzymatic assay (ELISA). CRP levels were determined by immunoturbidimetric method, while classical tumor marker levels were measured using chemiluminescent immunoassay. CXCL-8 concentrations were significantly higher in OC patients compared to healthy controls. We demonstrated significant differences between CXCL-8 concentrations and depth of tumor invasion (T factor) in OC patients and OSCC subgroup. In addition, CXCL-8 levels were found to correlate positively with T factor and CRP concentrations. The diagnostic sensitivity, negative predictive value and the area under ROC curve (AUC) of CXCL-8 were higher than those of classical tumor markers. Our findings suggest the potential usefulness of CXCL-8 in the diagnosis and progression of OC. However, due to the non-specific nature of this chemokine, further research is needed to clarify the usefulness of CXCL-8 as a tumor marker of OC.

Keywords: CXCL8; Chemokines; Oesophageal; Tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All patients gave informed consent and the present project was approved by the Local Ethics Committee (R-I-002/42/2015) of the Medical University of Bialystok (Poland).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Figures

Fig. 1
Fig. 1
Serum levels of proteins tested in patients with oesophageal cancer (OC) and in relation to its histological types (oesophageal squamous cell cancer—OSCC and oesophageal adenocarcinoma—OAC patients) in comparison with healthy controls
Fig. 2
Fig. 2
Serum concentrations of chemokine CXCL8 in patients with oesophageal cancer in relation to depth of tumor invasion (T factor)
Fig. 3
Fig. 3
Areas under ROC curves (AUC) for chemokine CXCL-8 (0.8315, p < 0.001), C-reactive protein (0.9092, p < 0.001), carcinoembryonic antigen (0.5238, p > 0.05), squamous cell cancer antigen (0.8250, p < 0.001) in oesophageal cancer (OC) patients
Fig. 4
Fig. 4
Areas under ROC curves (AUC) for chemokine CXCL-8 (0.7650, p < 0.001), C-reactive protein (0.8910, p < 0.001), carcinoembryonic antigen (0.6784, p = 0.046), squamous cell cancer antigen (0.7618, p < 0.001) in oesophageal adenocarcinoma (OAC) patients
Fig. 5
Fig. 5
Areas under ROC curves (AUC) for chemokine CXCL-8 (0.8690, p < 0.001), C-reactive protein (0.9195, p < 0.001), carcinoembryonic antigen (0.6376, p = 0.06), squamous cell cancer antigen (0.861, p < 0.001) in oesophageal squamous cell cancer (OSCC) patients
See this image and copyright information in PMC

References

    1. Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res. 2011;317:664–673. doi: 10.1016/j.yexcr.2010.11.013. - DOI - PubMed
    1. Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V. Multifaceted link between cancer and inflammation. Biosci Rep. 2012;32:1–15. doi: 10.1042/BSR20100136. - DOI - PubMed
    1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–444. doi: 10.1038/nature07205. - DOI - PubMed
    1. Del Prete A, Schioppa T, Tiberio L, Stabile H, Sozzani S. Leukocyte trafficking in tumor microenvironment. Curr Opin Pharmacol. 2017;35:40–47. doi: 10.1016/j.coph.2017.05.004. - DOI - PubMed
    1. Shrivastava MS, Hussain Z, Giricz O, et al. Targeting chemokine pathways in oesophageal adenocarcinoma. Cell Cycle. 2014;13:3320–3327. doi: 10.4161/15384101.2014.968426. - DOI - PMC - PubMed

Publication types

MeSH terms